247
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system

, &
Pages 800-807 | Received 01 Jul 2011, Accepted 26 Sep 2011, Published online: 11 Nov 2011

References

  • Fiocchi C. (2002). Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy. Minerva Gastroenterol Dietol, 48:215–226.
  • Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. (2001). The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl, 234:29–40.
  • Xu CT, Meng SY, Pan BR. (2004). Drug therapy for ulcerative colitis. World J Gastroenterol, 10:2311–2317.
  • Miozzari M, Ambühl PM. (2004). Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications. Nephrol Dial Transplant, 19:2615–2621.
  • Soen S. (2005). [Management of glucocorticoid-induced osteoporosis]. Clin Calcium, 15:616–624.
  • Yang L, Boyd K, Kaste SC, Kamdem Kamdem L, Rahija RJ, Relling MV. (2009). A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res, 27:169–175.
  • Kinget R, Kalala W, Vervoort L, van den Mooter G. (1998). Colonic drug targeting. J Drug Target, 6:129–149.
  • Van den Mooter G. (2006). Colon drug delivery. Expert Opin Drug Deliv, 3:111–125.
  • Klotz U, Schwab M. (2005). Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 57:267–279.
  • Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P et al. (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther, 299:775–781.
  • Yano H, Hirayama F, Kamada M, Arima H, Uekama K. (2002). Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. J Control Release, 79:103–112.
  • Tozaki H, Odoriba T, Okada N, Fujita T, Terabe A, Suzuki T et al. (2002). Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release, 82:51–61.
  • Kong H, Lee Y, Hong S, Han J, Choi B, Jung Y et al. (2009). Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis. J Drug Target, 17:450–458.
  • Freire C, Podczeck F, Veiga F, Sousa J. (2010). Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery. Drug Dev Ind Pharm, 36:161–172.
  • Bendas ER, Christensen JM, Ayres JW. (2010). Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets. Drug Dev Ind Pharm, 36:393–404.
  • Krenzlin S, Siepmann F, Wils D, Guerin-Deremaux L, Flament MP, Siepmann J. (2011). Non-coated multiparticulate matrix systems for colon targeting. Drug Dev Ind Pharm, 37:1150–1159.
  • Onishi H, Oosegi T, Machida Y, McGinity JW. (2005). Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: comparison of simple and conjugate microspheres. Drug Dev Ind Pharm, 31:597–605.
  • Onishi H, Oosegi T, Machida Y, McGinity JW. (2007). Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres. Drug Dev Ind Pharm, 33:848–854.
  • Oosegi T, Onishi H, Machida Y. (2008). Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. Eur J Pharm Biopharm, 68:260–266.
  • Oosegi T, Onishi H, Machida Y. (2008). Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. Int J Pharm, 348:80–88.
  • Onishi H, Oosegi T, Machida Y. (2008). Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Int J Pharm, 358:296–302.
  • Alvarez-Fuentes J, Fernández-Arévalo M, González-Rodríguez ML, Cirri M, Mura P. (2004). Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target, 12:607–612.
  • Maestrelli F, Cirri M, Corti G, Mennini N, Mura P. (2008). Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm, 69:508–518.
  • Khan MS, Sridhar BK, Srinatha A. (2010). Development and Evaluation of pH-Dependent Micro Beads for Colon Targeting. Indian J Pharm Sci, 72:18–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.